Considering the presence of PD-1+ CD4+ regulatory T cells in blood of vitiligo patients, PD-L1 fusion protein might give different results in the human setting, justifying further research on the effect of increased PD-1/PD-L1 signaling on both T cell subsets to determine treatment outcome. This evidence concerns the gene CD4 and vitiligo.